[C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure]

Rev Esp Cardiol. 2006 Jan;59(1):50-6.
[Article in Spanish]

Abstract

Introduction and objectives: Chagas disease is the most common cause of myocarditis in Latin America, including Venezuela. Some 25% of patients progress to chronic chagasic cardiomyopathy, which is characterized by heart failure and arrhythmias. The serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) have prognostic value in non-chagasic cardiopathy. The goal of this study was to investigate the relationship between the serum levels of CRP and IL-6 and the developmental stage of Chagas disease.

Patients and method: The study included 64 Chagas disease patients (34 female and 30 male; age 62.2 [1.7] years) and 20 healthy individuals (10 of each sex; age 50.4 [2.7] years). Clinical investigations included echocardiography and measurement of CRP and IL-6 serum levels using ELISAs. Chagas disease patients were graded according to Carrasco et al 1994 classification. Patients with ischemic cardiopathy, liver disease, autoimmune disease, a systemic inflammatory condition, immunosuppression, cancer, pericarditis, or endocarditis were excluded.

Results: Multiple regression analysis demonstrated an association between Chagas disease developmental stage and the serum IL-6 level. The serum CRP level increased during only the most advanced phase of the disease. In addition, a high left ventricular mass index was associated with a high IL-6 level and male sex.

Conclusions: IL-6 and CRP serum levels could be of prognostic value in assessing Chagas disease progression because there are significant correlations between elevated levels and the deterioration of cardiac function.

Publication types

  • English Abstract

MeSH terms

  • C-Reactive Protein / analysis*
  • Chagas Cardiomyopathy / blood*
  • Chagas Cardiomyopathy / etiology
  • Chagas Disease / blood*
  • Chagas Disease / complications
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Humans
  • Interleukin-6 / blood*
  • Male
  • Middle Aged

Substances

  • Interleukin-6
  • C-Reactive Protein